Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities / / edited by Awanish Mishra, Hitesh Kulhari
| Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities / / edited by Awanish Mishra, Hitesh Kulhari |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (457 pages) |
| Disciplina | 616.80461 |
| Collana | Medicine Series |
| Soggetto topico |
Pharmacology
Neurosciences Drug delivery systems Pharmaceutical chemistry Neuroscience Drug Delivery Pharmaceutics |
| ISBN | 981-9968-07-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section A: Anatomy and Physiology of Human Nervous System -- Chapter 1. Nanocarriers as an emerging tool for drug delivery to combat neurodegenerative diseases -- Chapter 2. Challenges in drug development for neurological disorders -- Chapter 3. Transporter systems and metabolism at the blood-brain barrier and blood-CSF barrier -- Section B: Pathophysiology and management of Neurological disorders -- Chapter 4. Pathophysiology and management approaches for Alzheimer’s Disease -- Chapter 5. Pathophysiology and management approaches for Parkinson's Disease -- Chapter 6 Pathophysiology and management approaches for Epilepsy -- Chapter 7. Pathophysiology and management approaches for Epilepsy -- Chapter 8. Pathophysiology and management approaches for Multiple Sclerosis, Huntington’s disease, and other neurodegenerative diseases -- Chapter 9. Genes Encoding Ion Channels in Neurotherapeutics: Opportunities and Challenges -- Chapter 10. Herbal approaches for the management of neurological disorders -- Section C: Drug Delivery Strategies in Neurological disorders -- Chapter 11. Essential Considerations for brain delivery of nanoformulations -- Chapter 12. Drug delivery strategies in Alzheimer’s disease -- Chapter 13. Drug delivery strategies in Parkinson's disease -- Chapter 14. Drug delivery strategies in Epilepsy -- Chapter 15. Drug delivery strategies in Traumatic Brain Injury -- Chapter 16. Drug delivery strategies in Multiple Sclerosis, Huntington’s disease, and other neurodegenerative diseases -- Chapter 17. Nose-to-brain strategies for neurological disorders -- Chapter 18. Drug delivery strategies for the delivery of natural compounds to the brain. |
| Record Nr. | UNINA-9910842283503321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Emerging Field of Human Neural Organoids, Transplants, and Chimeras : Science, Ethics, and Governance
| The Emerging Field of Human Neural Organoids, Transplants, and Chimeras : Science, Ethics, and Governance |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academies Press, , 2021 |
| Descrizione fisica | 1 online resource (153 pages) |
| Disciplina | 616.80461 |
| Altri autori (Persone) |
AffairsPolicy and Global
Committee on ScienceTechnology, and Law Committee on EthicalLegal, and Regulatory Issues Associated with Neural Chimeras and Organoids |
| Soggetto topico | Brain - Diseases |
| ISBN | 0-309-30408-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front Matter -- Summary -- 1. Introduction -- 2. The Science of Human Neural Organoids, Transplants, and Chimeras -- 3. Ethical Concerns -- 4. Oversight and Governance -- 5. Public Engagement -- 6. Findings of the Committee -- References -- Appendix A: Biographies of Committee and Staff Members -- Appendix B: Committee Meeting Agendas. |
| Altri titoli varianti | Emerging Field of Human Neural Organoids, Transplants, and Chimeras |
| Record Nr. | UNINA-9910821246003321 |
| Washington, D.C. : , : National Academies Press, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Toxicology of organophosphate and carbamate compounds [[electronic resource] /] / edited by Ramesh C. Gupta
| Toxicology of organophosphate and carbamate compounds [[electronic resource] /] / edited by Ramesh C. Gupta |
| Pubbl/distr/stampa | Amsterdam ; ; Boston, : Elsevier Academic Press, c2006 |
| Descrizione fisica | 1 online resource (781 p.) |
| Disciplina |
615.9/02 22
615.902 616.80461 |
| Altri autori (Persone) | GuptaRamesh C <1949-> (Ramesh Chandra) |
| Soggetto topico |
Organophosphorus compounds - Toxicology
Carbamates - Toxicology Cholinesterase inhibitors - Toxicology Pesticides - Toxicology Insecticides - Toxicology |
| ISBN |
1-281-03695-1
9786611036959 0-08-054310-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Toxicology of Organophosphate and Carbamate Compounds; Copyright Page; Contents; Contributors; Foreword; Section I: Uses, Abuses, & Epidemiology; Chapter 1. Introduction; Chapter 2. Classification and Uses of Organophosphates and Carbamates; Chapter 3. Therapeutic Uses of Cholinesterase Inhibitors in Neurodegenerative Diseases; Chapter 4. Coadministration of Memantine with Acetylcholinesterase Inhibitors: Preclinical and Clinical Evidence; Chapter 5. Cholinesterase Inhibitors as Chemical Warfare Agents: Community Preparedness Guidelines
Chapter 6. Organophosphates and the Gulf War SyndromeChapter 7. The Bhopal Accident and Methyl Isocyanate Toxicity; Chapter 8. Global Epidemiology of Organophosphate and Carbamate Poisonings; Section II: Pharmacokinetics & Metabolism; Chapter 9. Physiologically Based Pharmacokinetic Modeling of Organophosphorus and Carbamate Pesticides; Chapter 10. Metabolism of Organophosphorus and Carbamate Pesticides; Chapter 11. Interspecies Variation in Toxicity of Cholinesterase Inhibitors; Section III: Esterases, Receptors, Mechanisms, & Tolerance Development Chapter 12. Structure and Function of CholinesterasesChapter 13. Cholinesterase Pharmacogenetics; Chapter 14. Methods for Measuring Cholinesterase Activities in Human Blood; Chapter 15. Interactions of Organophosphorus and Carbamate Compounds with Cholinesterases; Chapter 16. Structure, Function, and Regulation of Carboxylesterases; Chapter 17. Noncholinesterase Mechanisms of Central and Peripheral Neurotoxicity: Muscarinic Receptors and Other Targets; Chapter 18. Paraoxonase Polymorphisms and Toxicity of Organophosphates Chapter 19. Tolerance Development to Toxicity of Cholinesterase InhibitorsSection IV: Organ Toxicity; Chapter 20. Central Nervous System Effects and Neurotoxicity; Chapter 21. Developmental Neurotoxicity of Organophosphates: A Case Study of Chlorpyrifos; Chapter 22. In Vitro Models for Testing Organophosphate-lnduced Neurotoxicity and Remediation; Chapter 23. Electrophysiological Mechanisms in Neurotoxicity of Organophosphates and Carbamates; Chapter 24. Behavioral Toxicity of Cholinesterase Inhibitors; Chapter 25. Peripheral Nervous System Effects and Delayed Neuropathy Chapter 26. Intermediate Syndrome in Organophosphate PoisoningChapter 27. Cardiovascular Toxicity of Cholinesterase lnhibitors; Chapter 28. Pulmonary Toxicity of Cholinesterase Inhibitors; Chapter 29. Approaches to Defining and Evaluating the Inhalation Pharmacology and Toxicology Hazards of Anticholinesterases; Chapter 30. Dermal Absorption/Toxicity of Organophosphates and Carbamates; Chapter 31. Local and Systemic Ophthalmic Pharmacology and Toxicology of Organophosphate and Carbamate Anticholinesterases; Chapter 32. Reproductive Toxicity of Organophosphate and Carbamate Pesticides Chapter 33. Placental Toxicity of Organophosphate and Carbamate Pesticides |
| Record Nr. | UNINA-9910784549503321 |
| Amsterdam ; ; Boston, : Elsevier Academic Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||